히알루론산의 특성 및 건성안을 포함한 안구표면질환에서의 사용

키워드

참고문헌 (103)

1. Sze JH, "Biotechnological production of hyaluronic acid : a mini review", 3 Biotech, 6, pp.67~ (2016)
2. Meyer K, "The polysaccharide of the vitreous humor", J Biol Chem, 107, pp.629~634 (1934)
3. Balazs EA, "Hyaluronic acid and replacement of vitreous and aqueous humor", Mod Probl Ophthalmol, 10, pp.3~21 (1972)
4. Norn MS, "Peroperative protection of cornea and conjunctiva", Acta Ophthalmol(Copenh), 59, pp.587~594 (1981)
5. Polack FM, "The treatment of dry eyes with Na hyaluronate(Healon®)", Cornea, 1, pp.133~136 (1982)
6. DeLuise VP, "The use of topical Healon tears in the management of refractory dry-eye syndrome", Ann Ophthalmol, 16, pp.823~824 (1984)
7. Stuart JC, "Dilute sodium hyaluronate(Healon)in the treatment of ocular surface disorders", Ann Ophthalmol, 17, pp.190~192 (1985)
8. Mengher LS, "Effect of sodium hyaluronate (0.1%) on break-up time (NIBUT) in patients with dry eyes", Br J Ophthalmol, 70, pp.442~447 (1986)
9. Sand BB, "Sodium hyaluronate in the treatment of keratoconjunctivitis sicca. A double masked clinical trial", Acta Ophthalmol(Copenh), 67, pp.181~183 (1989)
10. Hynnekleiv L, "Hyaluronic acid in the treatment of dry eye disease", Acta Ophthalmol, 100, pp.844~860 (2022)
11. Camillieri G, "Hyaluronan-induced stimulation of corneal wound healing is a pure pharmacological effect", J Ocul Pharmacol Ther, 20, pp.548~553 (2004)
12. Papa V, "Effect of topical 0.2% sodium hyaluronate on corneal wound healing after excimer laser keratectomy", Investig Ophthalmol Vis Sci, 45, pp.4863~ (2004)
13. Lin T, "Sodium hyaluronate eye drops treatment for superficial corneal abrasion caused by mechanical damage : a randomized clinical trial in the People's Republic of China", Drug Des Devel Ther, 9, pp.687~694 (2015)
14. Mencucci R, "Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery", J Cataract Refract Surg, 41, pp.1699~1704 (2015)
15. Ling K, "Use of commercially available sodium hyaluronate 0.18% eye drops for corneal epithelial healing in diabetic patients", Int Ophthalmol, 39, pp.2195~2203 (2019)
16. Chaidaroon W, "Effect of 2% hyaluronic acid on the rate of healing of corneal epithelial defect after pterygium surgery : a randomized controlled trial", Drug Des Devel Ther, 15, pp.4435~4443 (2021)
17. 남정우, "위눈꺼풀수술 후 0.15% 히알루론산 나트륨 점안액이 안구 표면에 미치는 임상적 효과", 대한안과학회지, 62(5), pp.612~620 (2021), 대한안과학회
18. Fraser JR, "Hyaluronan : its nature, distribution, functions and turnover", J Intern Med, 242, pp.27~33 (1997)
19. Kang H, "The most promising microneedle device : present and future of hyaluronic acid microneedle patch", Drug Deliv, 29, pp.3087~3110 (2022)
20. Posarelli C, "Cross-linked hyaluronic acid as tear film substitute", J Ocul Pharmacol Ther, 35, pp.381~387 (2019)
21. Pisárčik M, "Non-newtonian properties of hyaluronic acid aqueous solution", Colloids Surf A Physicochem Eng Asp, 97, pp.197~202 (1995)
22. López-García JS, "Autologous serum eye drops diluted with sodium hyaluronate : clinical and experimental comparative study", Acta Ophthalmol, 92, pp.e22~9 (2014)
23. Nakamura M, "Characterization of water retentive properties of hyaluronan", Cornea, 12, pp.433~436 (1993)
24. Zhang Z, "The nonlinear viscoelasticity of hyaluronic acid and its role in joint lubrication", Soft Matter, 11, pp.2596~2603 (2015)
25. Kaya S, "Effect of hyaluronic acid on tear film thickness as assessed with ultra-high resolution optical coherence tomography", Acta Ophthalmol, 93, pp.439~443 (2015)
26. Szegedi S, "Effect of single instillation of two hyaluronic acid-based topical lubricants on tear film thickness in patients with dry eye syndrome", J Ocul Pharmacol Ther, 34, pp.605~611 (2018)
27. Caretti L, "Efficacy of carbomer sodium hyaluronate trehalose vs hyaluronic acid to improve tear film instability and ocular surface discomfort after cataract surgery", Clin Ophthalmol, 13, pp.1157~1163 (2019)
28. Ntonti P, "Impact of 0.1% sodium hyaluronate and 0.2% sodium hyaluronate artificial tears on postoperative discomfort following cataract extraction surgery: a comparative study", Eye Vis(Lond), 6, pp.6~ (2019)
29. 김태환, "펨토초레이저 백내장수술 후 건성안에 대한 0.15% 무보존제 히알루론산나트륨의 임상적 효과", 대한안과학회지, 62(7), pp.922~930 (2021), 대한안과학회
30. Ghosh K, "Natural-Based Polymers for Biomedical Applications", pp.716~737 (2008), Woodhead Publishing
31. Litwiniuk M, "Hyaluronic acid in inflammation and tissue regeneration", Wounds, 28, pp.78~88 (2016)
32. Abatangelo G, "Hyaluronic acid : redefining its role", Cells, 9, pp.1743~ (2020)
33. Stern R, "Hyaluronan fragments : an information-rich system", Eur J Cell Biol, 85, pp.699~715 (2006)
34. Cooper CA, "Inflammation and hyaluronic acid", Altern Complement Ther, 14, pp.78~84 (2008)
35. Tammi RH, "Hyaluronan in human tumors : pathobiological and prognostic messages from cell-associated and stromal hyaluronan", Semin Cancer Biol, 18, pp.288~295 (2008)
36. Lardner E, "Detection of TSG-6-like protein in human corneal epithelium. Simultaneous presence with CD44 and hyaluronic acid", J Fr Ophtalmol, 43, pp.879~883 (2020)
37. Zhu SN, "Expression of adhesion molecule CD44 on human corneas", Br J Ophthalmol, 81, pp.80~84 (1997)
38. Crainie M, "Overexpression of the receptor for hyaluronan-mediated motility(RHAMM)characterizes the malignant clone in multiple myeloma : identification of three distinct RHAMM variants", Blood, 93, pp.1684~1696 (1999)
39. Chung JH, "Hyaluronate in healing of corneal alkali wound in the rabbit", Exp Eye Res, 48, pp.569~576 (1989)
40. Inoue M, "The effect of hyaluronic acid on corneal epithelial cell proliferation", Invest Ophthalmol Vis Sci, 34, pp.2313~2315 (1993)
41. Nakamura M, "Hyaluronan facilitates corneal epithelial wound healing in diabetic rats", Exp Eye Res, 64, pp.1043~1050 (1997)
42. Chung J, "Effect of Na-hyaluronan on stromal and endothelial healing in experimental corneal alkali wounds", Ophthalmic Res, 31, pp.432~439 (1999)
43. Gomes JA, "Sodium hyaluronate(hyaluronic acid)promotes migration of human corneal epithelial cells in vitro", Br J Ophthalmol, 88, pp.821~825 (2004)
44. Ho WT, "Enhanced corneal wound healing with hyaluronic acid and high-potassium artificial tears", Clin Exp Optom, 96, pp.536~541 (2013)
45. Di G, "Efficacy of sodium hyaluronate in murine diabetic ocular surface diseases", Cornea, 36, pp.1133~1138 (2017)
46. Seino S, "Topical hyaluronan alone promotes corneal epithelial cell migration whereas combination with benzalkonium chloride impairs epithelial wound healing", Cutan Ocul Toxicol, 39, pp.13~20 (2020)
47. Nishida T, "Hyaluronan stimulates corneal epithelial migration", Exp Eye Res, 53, pp.753~758 (1991)
48. Nakamura M, "Concentration and molecular weight dependency of rabbit corneal epithelial wound healing on hyaluronan", Curr Eye Res, 11, pp.981~986 (1992)
49. Aruffo A, "CD44 is the principal cell surface receptor for hyaluronate", Cell, 61, pp.1303~1313 (1990)
50. Yu FX, "Expression and distribution of adhesion molecule CD44 in healing corneal epithelia", Invest Ophthalmol Vis Sci, 39, pp.710~717 (1998)
51. Abbasi AM, "CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells", Eur J Cancer, 29A, pp.1995~2002 (1993)
52. Lesley J, "CD44 and its interaction with extracellular matrix", Adv Immunol, 54, pp.271~335 (1993)
53. "Reduction in keratitis and CD44 expression in dry-eye patients treated with a unique 0.18% sodium hyaluronate solution. Günthert U. CD44: a multitude of isoforms with diverse functions", Curr Top Microbiol Immunol, 184, pp.47~63 (1993)
54. Mackay CR, "Expression and modulation of CD44 variant isoforms in humans", J Cell Biol, 124, pp.71~82 (1994)
55. Baudouin F, "Reduction in keratitis and CD44 expression in dry-eye patients treated with a unique 0. 18%sodium hyaluronate solution", Investig Ophthalmol Vis Sci, 42, pp.S32~ (2001)
56. Chung JH, "Effect of topically applied Na-hyaluronan on experimental corneal alkali wound healing", Korean J Ophthalmol, 10, pp.68~75 (1996)
57. Craig JP, "TFOS DEWS II report executive summary", Ocul Surf, 15, pp.802~812 (2017)
58. Luo L, "Hyperosmolarity-induced apoptosis in human corneal epithelial cells is mediated by cytochrome c and MAPK pathways", Cornea, 26, pp.452~460 (2007)
59. Reinoso R, "Differential cell proliferation, apoptosis, and immune response in healthy and evaporative-type dry eye conjunctival epithelia", Invest Ophthalmol Vis Sci, 52, pp.4819~4828 (2011)
60. Png E, "Hyperosmolarity-mediated mitochondrial dysfunction requires transglutaminase-2 in human corneal epithelial cells", J Cell Physiol, 226, pp.693~699 (2011)
61. Clouzeau C, "Hyperosmolarity potentiates toxic effects of benzalkonium chloride on conjunctival epithelial cells in vitro", Mol Vis, 18, pp.851~863 (2012)
62. Baudouin C, "Randomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye disease", Eur J Ophthalmol, 22, pp.751~761 (2012)
63. Jones L, "TFOS DEWS II management and therapy report", Ocul Surf, 15, pp.575~628 (2017)
64. Iester M, "Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis sicca", Eye(Lond), 14(Pt 6), pp.892~898 (2000)
65. You IC, "Comparison of 0.1%, 0.18%, and 0.3%hyaluronic acid eye drops in the treatment of experimental dry eye", J Ocul Pharmacol Ther, 34, pp.557~564 (2018)
66. Kong X, "Sodium hyaluronate's effect on xerophthalmia : a meta-analysis of randomized controlled trials", Curr Med Res Opin, 32, pp.477~484 (2016)
67. Ang BCH, "Sodium hyaluronate in the treatment of dry eye syndrome : a systematic review and meta-analysis", Sci Rep, 7, pp.9013~ (2017)
68. 송재경, "Efficacy of Carboxymethylcellulose and Hyaluronate in Dry Eye Disease: A Systematic Review and Meta-Analysis", Korean Journal of Family Medicine, 38(1), pp.2~7 (2017), 대한가정의학회
69. Yang YJ, "A meta-analysis of the efficacy of hyaluronic acid eye drops for the treatment of dry eye syndrome", Int J Environ Res Public Health, 18, pp.2383~ (2021)
70. Sanchez MA, "Comparative analysis of carmellose 0.5% versus hyaluronate 0.15% in dry eye: a flow cytometric study", Cornea, 29, pp.167~171 (2010)
71. Shimmura S, "Sodium hyaluronate eyedrops in the treatment of dry eyes", Br J Ophthalmol, 79, pp.1007~1011 (1995)
72. Vogel R, "Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena)", Am J Ophthalmol, 149, pp.594~601 (2010)
73. Condon PI, "Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w", v) sodium hyaluronate solution (fermavisc) in the treatment of dry eye syndrome, 1999, pp.83, 1121~1124
74. Johnson ME, "Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye", Graefes Arch Clin Exp Ophthalmol, 244, pp.109~112 (2006)
75. Baeyens V, "Efficacy of 0.18% hypotonic sodium hyaluronate ophthalmic solution in the treatment of signs and symptoms of dry eye disease", J Fr Ophtalmol, 35, pp.412~419 (2012)
76. Pinto-Fraga J, "Efficacy and safety of 0.2% hyaluronic acid in the management of dry eye disease", Eye Contact Lens, 43, pp.57~63 (2017)
77. López-de la Rosa A, "Safety and efficacy of an artificial tear containing 0.3% hyaluronic acid in the management of moderate-to-severe dry eye disease", Eye Contact Lens, 43, pp.383~388 (2017)
78. Aragona P, "Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye", Br J Ophthalmol, 86, pp.181~184 (2002)
79. Carracedo G, "Evaluation of tear meniscus by optical coherence tomography after different sodium hyaluronate eyedrops instillation", Acta Ophthalmol, 97, pp.e162~9 (2019)
80. Akiyama-Fukuda R, "Evaluation of tear meniscus dynamics using anterior segment swept-source optical coherence tomography after topical solution instillation for dry eye", Cornea, 35, pp.654~658 (2016)
81. Vandermeer G, "Comparison of objective optical quality measured by double-pass aberrometry in patients with moderate dry eye : normal saline vs. artificial tears : a pilot study", J Fr Ophtalmol, 41, pp.e51~7 (2018)
82. Li XM, "Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery", Cornea, 26(9 Suppl 1), pp.S16~20 (2007)
83. Kasetsuwan N, "Incidence and pattern of dry eye after cataract surgery", PLoS One, 8, pp.e 78657.~ (2013)
84. Xue W, "Long-term impact of dry eye symptoms on vision-related quality of life after phacoemulsification surgery", Int Ophthalmol, 39, pp.419~429 (2019)
85. Kohlhaas M, "Corneal sensation after cataract and refractive surgery", J Cataract Refract Surg, 24, pp.1399~1409 (1998)
86. Ram J, "Outcomes of phacoemulsification in patients with dry eye", J Cataract Refract Surg, 28, pp.1386~1389 (2002)
87. Roberts CW, "Dry eye symptoms following cataract surgery", Insight, 32, pp.14~21 (2007)
88. 조양경, "Dry Eye After Cataract Surgeryand Associated Intraoperative Risk Factors", Korean Journal of Ophthalmology, 23(2), pp.65~73 (2009), 대한안과학회
89. Sánchez MA, "The effect of preservative-free HP-guar on dry eye after phacoemulsification : a flow cytometric study", Eye(Lond), 24, pp.1331~1337 (2010)
90. Albarrán C, "Influence of the tear film on optical quality of the eye", Cont Lens Anterior Eye, 20, pp.129~135 (1997)
91. Denoyer A, "Tear film aberration dynamics and vision-related quality of life in patients with dry eye disease", Ophthalmology, 119, pp.1811~1818 (2012)
92. Jee D, "Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome", J Cataract Refract Surg, 41, pp.756~763 (2015)
93. Labiris G, "Impact of polyethylene glycol 400", propylene glycol, Eye Vis(Lond), pp.2017, 4[DOI]
94. Damasceno RW, "Upper blepharoplasty with or without resection of the orbicularis oculi muscle : a randomized double-blind left-right study", Ophthalmic Plast Reconstr Surg, 27, pp.195~197 (2011)
95. Prischmann J, "Dry eye symptoms and chemosis following blepharoplasty : a 10-year retrospective review of 892 cases in a single-surgeon series", JAMA Facial Plast Surg, 15, pp.39~46 (2013)
96. Gomes JAP, "TFOS DEWS II iatrogenic report", Ocul Surf, 15, pp.511~538 (2017)
97. Thompson CB, "Apoptosis in the pathogenesis and treatment of disease", Science, 267, pp.1456~1462 (1995)
98. Adler R, "Mechanisms of photoreceptor death in retinal degenerations. From the cell biology of the 1990s to the ophthalmology of the 21st century?", Arch Ophthalmol, 114, pp.79~83 (1996)
99. Wee WR, "Effect of artificial tears on cultured keratocytes in vitro", Cornea, 14, pp.273~279 (1995)
100. Ayaki M, "Cytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cells", Clin Exp Ophthalmol, 36, pp.553~559 (2008)
101. 김호윤, "제품화된 무방부제 힐론 점안제가 각막상피세포에 미치는 영향", 대한안과학회지, 55(11), pp.1698~1705 (2014), 대한안과학회
102. 이종수, "무보존제 히알루론산나트륨 점안이 각막상피세포에 미치는 장기적 영향", 대한안과학회지, 56(12), pp.1945~1952 (2015), 대한안과학회
103. 이은정, "히알우론산나트륨 점안액의 장기 사용으로 인한 독성 각막염 1예", 대한안과학회지, 56(2), pp.291~295 (2015), 대한안과학회

관련 논문AI추천